Delays in Hepatitis B Immunization Series Completion in People With Human Immunodeficiency Virus.

Daanish SheikhKristen A StaggersJennifer CareyWendy A KeitelRobert L AtmarHana M El SahlyJennifer A Whitaker

Published in: Open forum infectious diseases (2023)

Strategies are needed to increase HBV vaccine completion rates in our study population, particularly among those with CD4 cell counts <200/μL or with a substance use disorder.

Keyphrases

human immunodeficiency virus
hepatitis c virus
antiretroviral therapy
hepatitis b virus
hiv infected
single cell
hiv aids
cell therapy
peripheral blood
mesenchymal stem cells